{"id":116151,"date":"2026-06-12T14:20:38","date_gmt":"2026-06-12T08:50:38","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=116151"},"modified":"2026-06-12T14:20:41","modified_gmt":"2026-06-12T08:50:41","slug":"why-is-jubilant-pharmova-share-price-falling","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/","title":{"rendered":"Why Is Jubilant Pharmova Share Price Falling Key Reasons 2026"},"content":{"rendered":"<div class=\"meta-block\"><\/div>\n<p style=\"border-left: 4px solid #1F4E79; background: #EBF3FB; padding: 10px 16px; font-style: italic;\"><em>Jubilant Pharmova share price is down 20% from Rs 1,200 to Rs 964 in 2026. FII selling, earnings pressure and valuation de-rating drive the decline.<\/em><\/p>\n<p>The <strong><a href=\"https:\/\/univest.in\/user\/stocks\/jublpharma\/jubilant-pharmova-ltd-share-price-today\">Jubilant Pharmova<\/a> share price falling<\/strong> trend has become a key investor concern in 2026. With <strong>Jubilant Pharmova share price falling<\/strong> approximately 20 percent from its 52 week high of Rs 1,200 to current levels near Rs 964, investors are asking whether this correction represents a buying opportunity or signals deeper structural challenges. Jubilant Pharmova (NSE: JUBLPHARMA), listed in the Pharmaceutical and Radio Pharmaceuticals space, has witnessed sustained selling pressure through FY26.<\/p>\n<p><a href=\"https:\/\/univest.in\/user\/log-in\"><strong>Click Here Get Free Investment Predictions<\/strong><\/a><\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#About_Jubilant_Pharmova\" title=\"About Jubilant Pharmova\">About Jubilant Pharmova<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Why_Is_Jubilant_Pharmova_Share_Price_Falling_Key_Reasons\" title=\"Why Is Jubilant Pharmova Share Price Falling: Key Reasons\">Why Is Jubilant Pharmova Share Price Falling: Key Reasons<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#1_Q4_FY26_Results_and_Earnings_Deceleration\" title=\"1. Q4 FY26 Results and Earnings Deceleration\">1. Q4 FY26 Results and Earnings Deceleration<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#2_FII_Selling_and_Broad_Market_Correction\" title=\"2. FII Selling and Broad Market Correction\">2. FII Selling and Broad Market Correction<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#3_Sector-Specific_Headwinds_in_Pharmaceutical_and_Radio_Pharmaceuticals\" title=\"3. Sector-Specific Headwinds in Pharmaceutical and Radio Pharmaceuticals\">3. Sector-Specific Headwinds in Pharmaceutical and Radio Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#4_Valuation_De-Rating_from_Peak_Multiples\" title=\"4. Valuation De-Rating from Peak Multiples\">4. Valuation De-Rating from Peak Multiples<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#5_Small_and_Mid_Cap_Liquidity_Squeeze\" title=\"5. Small and Mid Cap Liquidity Squeeze\">5. Small and Mid Cap Liquidity Squeeze<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#6_Global_Macroeconomic_Uncertainty\" title=\"6. Global Macroeconomic Uncertainty\">6. Global Macroeconomic Uncertainty<\/a><\/li><\/ul><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Financial_Performance_Analysis_of_Jubilant_Pharmova\" title=\"Financial Performance Analysis of Jubilant Pharmova\">Financial Performance Analysis of Jubilant Pharmova<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Technical_Signals_What_the_Charts_Are_Saying\" title=\"Technical Signals What the Charts Are Saying\">Technical Signals What the Charts Are Saying<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Can_Jubilant_Pharmova_Share_Price_Recover\" title=\"Can Jubilant Pharmova Share Price Recover\">Can Jubilant Pharmova Share Price Recover<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Conclusion\" title=\"Conclusion\">Conclusion<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-14\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Why_is_Jubilant_Pharmova_share_price_falling_in_2026\" title=\"Why is Jubilant Pharmova share price falling in 2026?\">Why is Jubilant Pharmova share price falling in 2026?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-15\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#What_is_the_52_week_high_and_low_of_Jubilant_Pharmova\" title=\"What is the 52 week high and low of Jubilant Pharmova?\">What is the 52 week high and low of Jubilant Pharmova?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-16\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#Should_I_buy_Jubilant_Pharmova_shares_at_current_levels\" title=\"Should I buy Jubilant Pharmova shares at current levels?\">Should I buy Jubilant Pharmova shares at current levels?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-17\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#What_are_the_recovery_triggers_for_Jubilant_Pharmova\" title=\"What are the recovery triggers for Jubilant Pharmova?\">What are the recovery triggers for Jubilant Pharmova?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-18\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#What_are_the_key_downside_risks_to_Jubilant_Pharmova_stock\" title=\"What are the key downside risks to Jubilant Pharmova stock?\">What are the key downside risks to Jubilant Pharmova stock?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-19\" href=\"https:\/\/univest.in\/blogs-2\/why-is-jubilant-pharmova-share-price-falling\/#What_is_the_market_cap_of_Jubilant_Pharmova\" title=\"What is the market cap of Jubilant Pharmova?\">What is the market cap of Jubilant Pharmova?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"About_Jubilant_Pharmova\"><\/span><strong>About Jubilant Pharmova<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Pharmaceutical company with radio-pharma, allergy therapy, CDMO and generic businesses. Revenue Rs 4,500 crore. 52W high Rs 1,200, CMP Rs 964, down 20 percent. The stock is trading at approximately Rs 964, down approximately 20 percent from its 52 week high of Rs 1,200. The 52 week low stands at Rs 750. The <strong>Jubilant Pharmova share price falling<\/strong> trend reflects both sector headwinds and company-specific pressures.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Parameter<\/th>\n<th>Value<\/th>\n<\/tr>\n<tr>\n<td>NSE Ticker<\/td>\n<td>JUBLPHARMA<\/td>\n<\/tr>\n<tr>\n<td>Sector<\/td>\n<td>Pharmaceutical and Radio Pharmaceuticals<\/td>\n<\/tr>\n<tr>\n<td>CMP (2026)<\/td>\n<td>Rs 964<\/td>\n<\/tr>\n<tr>\n<td>52 Week High<\/td>\n<td>Rs 1,200<\/td>\n<\/tr>\n<tr>\n<td>52 Week Low<\/td>\n<td>Rs 750<\/td>\n<\/tr>\n<tr>\n<td>Decline from 52W High<\/td>\n<td>Approximately 20 percent<\/td>\n<\/tr>\n<tr>\n<td>Market Cap<\/td>\n<td>Rs 6,000 crore (approx)<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>18x<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<div style=\"background: #E8EAFF; border-radius: 14px; padding: 28px 32px 24px 32px; margin: 24px 0; font-family: -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,sans-serif; cursor: pointer; max-width: 100%; box-sizing: border-box;\">\n<p style=\"font-size: 20px; font-weight: bold; color: #0a0a23; margin: 0 0 12px 0; line-height: 1.3;\">3 Stocks Building Serious Momentum Right Now<\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">When <strong style=\"color: #0a0a23;\">Univest analysts<\/strong> identify high-conviction stock opportunities, <em>investors pay attention.<\/em><\/p>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 14px 0; line-height: 1.6;\">Our research team has now shortlisted the <strong style=\"color: #0a0a23;\">Top Stocks to Buy<\/strong> based on current market momentum, sector trends &amp; growth potential for 2026.<\/p>\n<ul style=\"margin: 0 0 16px 20px; padding: 0; color: #3a3a5c; font-size: 15px; line-height: 1.8;\">\n<li>Discover stocks investors are actively accumulating<\/li>\n<li>High-conviction opportunities backed by research<\/li>\n<li>Designed for the next phase of market growth<\/li>\n<\/ul>\n<p style=\"font-size: 15px; color: #3a3a5c; margin: 0 0 20px 0;\">Unlock the latest <a style=\"color: #3b7fff; font-weight: bold; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">Top Stock Picks<\/a> now on Univest<\/p>\n<p><a style=\"display: inline-block; background: #3B7FFF; color: #fff; font-size: 15px; font-weight: 600; padding: 13px 28px; border-radius: 50px; letter-spacing: 0.2px; text-decoration: none;\" href=\"https:\/\/univest.in\/user\/payment?planType=ALL_PRO%20PLANS\" target=\"_blank\" rel=\"noopener\">See the Stocks \u2192<\/a><\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Why_Is_Jubilant_Pharmova_Share_Price_Falling_Key_Reasons\"><\/span><strong>Why Is Jubilant Pharmova Share Price Falling: Key Reasons<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use the <a href=\"https:\/\/univest.in\/screeners\">Univest Screener<\/a> to check live fundamentals of Jubilant Pharmova and compare with peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"1_Q4_FY26_Results_and_Earnings_Deceleration\"><\/span><strong>1. Q4 FY26 Results and Earnings Deceleration<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>A key driver behind the <strong>Jubilant Pharmova share price falling<\/strong> is the deceleration in earnings growth relative to the elevated expectations priced in at its 52 week high of Rs 1,200. Revenue and profitability have come under pressure from input cost inflation, competitive pricing constraints, and higher operating expenditure. The market is now recalibrating to a more moderate earnings trajectory, which has become a core driver of the <strong>Jubilant Pharmova share price falling<\/strong> below prior analyst targets.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"2_FII_Selling_and_Broad_Market_Correction\"><\/span><strong>2. FII Selling and Broad Market Correction<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The US reciprocal tariff announcement imposing a 26 percent levy on Indian goods triggered a broad FII selloff from Indian equities. The <strong>Jubilant Pharmova share price falling<\/strong> by 20 percent from its peak reflects the combination of macro-level FII selling and company-specific headwinds. FII outflows from the Pharmaceutical and Radio Pharmaceuticals sector have been particularly pronounced, amplifying the correction in Jubilant Pharmova.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"3_Sector-Specific_Headwinds_in_Pharmaceutical_and_Radio_Pharmaceuticals\"><\/span><strong>3. Sector-Specific Headwinds in Pharmaceutical and Radio Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>The Pharmaceutical and Radio Pharmaceuticals sector faced its own challenges in FY26, with analyst earnings estimates revised downward as input cost inflation, competitive pricing pressures, and demand moderation weighed on sector outlook. This sector de-rating has driven the <strong>Jubilant Pharmova share price falling<\/strong> trend throughout 2026 as institutional investors reduced overall sector exposure.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"4_Valuation_De-Rating_from_Peak_Multiples\"><\/span><strong>4. Valuation De-Rating from Peak Multiples<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>At its 52 week high of Rs 1,200, Jubilant Pharmova was trading at valuation multiples above its historical average. As results came in below peak expectations and sector sentiment turned cautious, the market applied lower multiples to Jubilant Pharmova earnings. This valuation de-rating from Rs 1,200 to Rs 964 is one of the core mechanisms behind the 20 percent correction in the <strong>Jubilant Pharmova share price falling<\/strong> phase.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"5_Small_and_Mid_Cap_Liquidity_Squeeze\"><\/span><strong>5. Small and Mid Cap Liquidity Squeeze<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>With a market capitalisation of approximately Rs 6,000 crore, Jubilant Pharmova is exposed to the liquidity dynamics of the small and mid cap segment, which experienced a sharp liquidity squeeze in FY25-26. When domestic mutual funds face redemption pressure and retail investors turn risk-averse, smaller companies bear disproportionate selling pressure, amplifying the <strong>Jubilant Pharmova share price falling<\/strong> trend.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"6_Global_Macroeconomic_Uncertainty\"><\/span><strong>6. Global Macroeconomic Uncertainty<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p>India&#8217;s equity market in FY26 faced macro headwinds including global tariff wars, crude oil price volatility, and currency pressure. The <strong>Jubilant Pharmova share price falling<\/strong> trend has been reinforced by this macro overhang that keeps institutional buyers cautious even when individual company fundamentals do not fully justify the magnitude of the decline.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Financial_Performance_Analysis_of_Jubilant_Pharmova\"><\/span><strong>Financial Performance Analysis of Jubilant Pharmova<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The key financial metrics driving the <strong>Jubilant Pharmova share price falling<\/strong> narrative are visible in both recent quarterly trends and valuation de-rating. The stock has fallen 20 percent from its 52 week high of Rs 1,200 to Rs 964. The market cap has contracted to approximately Rs 6,000 crore. Investors tracking the <strong>Jubilant Pharmova share price falling<\/strong> should monitor Q4 FY26 results and management commentary on margin and revenue recovery.<\/p>\n<table>\n<tbody>\n<tr>\n<th>Key Metric<\/th>\n<th>Current Level<\/th>\n<th>52 Week Peak<\/th>\n<th>Trend<\/th>\n<\/tr>\n<tr>\n<td>Share Price<\/td>\n<td>Rs 964<\/td>\n<td>Rs 1,200<\/td>\n<td>Down 20 percent<\/td>\n<\/tr>\n<tr>\n<td>Market Cap (Rs Cr)<\/td>\n<td>Rs 6,000 crore<\/td>\n<td>Higher at 52W peak<\/td>\n<td>Compressed with price<\/td>\n<\/tr>\n<tr>\n<td>Trailing P\/E<\/td>\n<td>18x<\/td>\n<td>Higher at 52W high<\/td>\n<td>Multiple compressed<\/td>\n<\/tr>\n<tr>\n<td>52 Week Range<\/td>\n<td colspan=\"3\">Rs 750 to Rs 1,200<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2><span class=\"ez-toc-section\" id=\"Technical_Signals_What_the_Charts_Are_Saying\"><\/span><strong>Technical Signals What the Charts Are Saying<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>On the technical charts, the <strong>Jubilant Pharmova share price falling<\/strong> pattern is confirmed by the stock trading below its 50 day, 100 day, and 200 day simple moving averages, which are sloping downward. Since its 52 week high of Rs 1,200, Jubilant Pharmova has formed a pattern of lower highs and lower lows. Key support is at the 52 week low of Rs 750. Overhead resistance is at the Rs 1,200 zone. <em>Download the <a href=\"http:\/\/apps.apple.com\/in\/app\/univest-stocks-investment\/id6443753518\" rel=\"nofollow noopener\" target=\"_blank\">Univest iOS App<\/a> or <a href=\"http:\/\/play.google.com\/store\/apps\/details?id=com.univest.capp&amp;hl=en_IN\" rel=\"nofollow noopener\" target=\"_blank\">Univest Android App<\/a> to track Jubilant Pharmova live price and get daily stock recommendations.<\/em><\/p>\n<h2><span class=\"ez-toc-section\" id=\"Can_Jubilant_Pharmova_Share_Price_Recover\"><\/span><strong>Can Jubilant Pharmova Share Price Recover<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Despite the headwinds driving the <strong>Jubilant Pharmova share price falling<\/strong>, recovery catalysts exist. A quarterly earnings result beating reduced analyst expectations could trigger a short-covering rally from oversold levels. Any positive inflection in the Pharmaceutical and Radio Pharmaceuticals sector, reversal of FII selling as global macro conditions improve, or a broader small and mid cap recovery could arrest the <strong>Jubilant Pharmova share price falling<\/strong> trend. At Rs 964, a significant portion of the bad news may already be priced in, creating a potentially attractive entry point for patient investors with a 2 to 3 year horizon.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Conclusion\"><\/span><strong>Conclusion<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>The <strong>Jubilant Pharmova share price falling<\/strong> by approximately 20 percent from its 52 week high of Rs 1,200 to the current Rs 964 reflects broad market headwinds, FII selling, earnings impact, and valuation de-rating. Investors monitoring the <strong>Jubilant Pharmova share price falling<\/strong> should closely watch upcoming earnings guidance, FII ownership shifts, and macro signals for any sustainable reversal. For real-time tracking, visit Univest.<\/p>\n<p style=\"background: #C0392B; color: #fff; font-weight: bold; padding: 12px 16px; border-radius: 4px;\"><strong>Disclaimer Note:<\/strong> Investments in securities are subject to market risk. This content is for educational purposes only and does not constitute investment advice. Data sourced from publicly available open sources and may not be completely accurate. SEBI Registration No. INH000013776.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Jubilant_Pharmova_share_price_falling_in_2026\"><\/span><strong>Why is Jubilant Pharmova share price falling in 2026?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The Jubilant Pharmova share price falling in 2026 is driven by FII selling following the US tariff announcement in 2026, sector headwinds in the Pharmaceutical and Radio Pharmaceuticals space, earnings deceleration, and valuation de-rating from peak multiples. The decline totals approximately 20 percent from the 52 week high of Rs 1,200 to the current Rs 964.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_52_week_high_and_low_of_Jubilant_Pharmova\"><\/span><strong>What is the 52 week high and low of Jubilant Pharmova?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The 52 week high of Jubilant Pharmova is Rs 1,200 and the 52 week low is Rs 750. The current price of approximately Rs 964 represents a decline of about 20 percent from the 52 week high.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Should_I_buy_Jubilant_Pharmova_shares_at_current_levels\"><\/span><strong>Should I buy Jubilant Pharmova shares at current levels?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Whether to buy Jubilant Pharmova at Rs 964 during the Jubilant Pharmova share price falling phase depends on your investment horizon and risk appetite. The stock has fallen 20 percent from its peak. Always consult a SEBI registered financial advisor before making any investment decision.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_recovery_triggers_for_Jubilant_Pharmova\"><\/span><strong>What are the recovery triggers for Jubilant Pharmova?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key recovery catalysts for Jubilant Pharmova include a quarterly earnings result beating reduced analyst expectations, reversal of FII selling as global macro conditions improve, positive sector re-rating in the Pharmaceutical and Radio Pharmaceuticals space, and a broader Indian market recovery.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_are_the_key_downside_risks_to_Jubilant_Pharmova_stock\"><\/span><strong>What are the key downside risks to Jubilant Pharmova stock?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Key downside risks include continued earnings estimate downgrades, further FII selling, unexpected regulatory or competitive developments in the Pharmaceutical and Radio Pharmaceuticals sector, and a deeper correction in the broader Indian equity segment testing the 52 week low of Rs 750.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_cap_of_Jubilant_Pharmova\"><\/span><strong>What is the market cap of Jubilant Pharmova?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The current market capitalisation of Jubilant Pharmova is approximately Rs 6,000 crore based on the current price of Rs 964. The market cap has compressed from its peak levels as the Jubilant Pharmova share price falling trend has persisted through 2026.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Why is Jubilant Pharmova share price falling? Key reasons behind decline from Rs 1,200 to Rs 964, financial analysis, and what investors should watch in 2026.<\/p>\n","protected":false},"author":28,"featured_media":116385,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[3802,3818],"class_list":["post-116151","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","tag-news","tag-share-price-falling"],"metadata":{"rank_math_internal_links_processed":["1"],"_edit_lock":["1781254244:28"],"_last_editor_used_jetpack":["block-editor"],"rank_math_primary_category":["842"],"rank_math_seo_score":["84"],"rank_math_title":["Why Is Jubilant Pharmova Share Price Falling Key Reasons 2026"],"rank_math_description":["Why is Jubilant Pharmova share price falling? Key reasons behind the decline from Rs 1,200 to Rs 964, financial analysis, and what investors should watch in 2026."],"rank_math_focus_keyword":["Jubilant Pharmova Share Price Falling"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"],"_thumbnail_id":["116385"],"_edit_last":["28"],"_ez-toc-disabled":[""],"_ez-toc-insert":[""],"_ez-toc-header-label":[""],"_ez-toc-alignment":["none"],"_ez-toc-heading-levels":["a:0:{}"],"_ez-toc-alttext":[""],"_ez-toc-visibility_hide_by_default":[""],"_ez-toc-hide_counter":[""],"_ez-toc-exclude":[""],"_ez-toc-position-specific":["before"],"stm_select_gm_zoom":[""],"stm_agenda":[""],"stm_host":[""],"stm_select_approved_denied":[""],"stm_multiselect_approved":[""],"stm_multiselect_denied":[""],"stm_date":[""],"stm_time":[""],"stm_timezone":[""],"stm_duration":[""],"stm_password":[""],"stm_waiting_room":[""],"stm_join_before_host":[""],"stm_host_join_start":[""],"stm_start_after_participants":[""],"stm_mute_participants":[""],"stm_enforce_login":[""],"stm_alternative_hosts":[""],"top_bar_custom_style":[""],"top_bar_bg":[""],"wc_top_bar_cart_custom_style":[""],"wc_top_bar_cart_color":[""],"wc_top_bar_cart_icon_color_hover":[""],"wc_top_bar_cart_counter_color":[""],"wc_top_bar_cart_counter_color_hover":[""],"wc_top_bar_cart_counter_bg":[""],"wc_top_bar_cart_counter_bg_hover":[""],"top_bar_wpml_switcher_custom_style":[""],"wpml_switcher_color":[""],"top_bar_wpml_switcher_bg":[""],"top_bar_wpml_switcher_bg_hover":[""],"top_bar_wpml_switcher_color_hover":[""],"top_bar_socials_custom_style":[""],"top_bar_socials_color":[""],"top_bar_socials_color_hover":[""],"top_bar_search_custom_style":[""],"top_bar_search_color":[""],"top_bar_search_icon_color_hover":[""],"top_bar_contact_info_style":[""],"top_bar_contact_info_color":[""],"top_bar_contact_info_link_color":[""],"top_bar_contact_info_link_color_hover":[""],"top_bar_contact_info_select_bg":[""],"top_bar_contact_info_select_color":[""],"top_bar_contact_info_select_drop_bg":[""],"top_bar_contact_info_select_items_bg":[""],"top_bar_contact_info_select_items_color":[""],"top_bar_contact_info_select_items_hover":[""],"header_inverse":["default"],"enable_header_transparent":["off"],"header_nav_custom_style":[""],"header_bg":[""],"header_shadow":[""],"wc_cart_custom_style":[""],"wc_cart_icon_color":[""],"wc_cart_icon_color_hover":[""],"wc_cart_counter_color":[""],"wc_cart_counter_color_hover":[""],"wc_cart_counter_bg":[""],"wc_cart_counter_bg_hover":[""],"header_wpml_switcher_custom_style":[""],"header_wpml_switcher_color":[""],"header_wpml_switcher_color_hover":[""],"header_wpml_switcher_bg":[""],"header_wpml_switcher_bg_hover":[""],"header_socials_custom_style":[""],"header_socials_color":[""],"header_socials_color_hover":[""],"header_search_custom_style":[""],"header_search_icon_color":[""],"header_search_icon_color_hover":[""],"header_contact_info_style":[""],"header_contact_info_color":[""],"header_contact_info_link_color":[""],"header_contact_info_link_color_hover":[""],"header_button_custom_style":[""],"header_button_color":[""],"header_button_color_hover":[""],"header_button_bg":[""],"header_button_bg_hover":[""],"header_nav_menu_customize":[""],"header_nav_menu_link_color":[""],"header_nav_menu_link_color_hover":[""],"header_nav_menu_link_color_active":[""],"header_nav_menu_link_arrow_color":[""],"header_nav_menu_link_arrow_color_hover":[""],"header_nav_menu_level_1_bg":[""],"header_nav_menu_level_1_link_color":[""],"header_nav_menu_level_1_link_color_hover":[""],"header_nav_menu_level_1_link_bg_hover":[""],"header_nav_menu_level_1_link_arrow_color":[""],"header_nav_menu_level_1_link_arrow_color_hover":[""],"header_nav_menu_level_2_bg":[""],"header_nav_menu_level_2_link_color":[""],"header_nav_menu_level_2_link_color_hover":[""],"header_nav_menu_level_2_link_bg_hover":[""],"header_mega_menu_bg":[""],"header_mega_menu_title_color":[""],"header_mega_menu_title_color_hover":[""],"header_mega_menu_description_color":[""],"header_mega_menu_description_link_color":[""],"header_mega_menu_description_link_color_hover":[""],"header_mega_menu_color":[""],"header_mega_menu_color_hover":[""],"header_mega_menu_border_color":[""],"header_mega_menu_icons_color":[""],"header_nav_menu_customize_end":[""],"hfe_enabled_notice":[""],"disable_title_box":["default"],"hfe_disabled":[""],"enable_transparent":["default"],"title_box_title_bg_color":[""],"title_box_bg_custom_image":["default"],"title_box_bg_image":[""],"title_box_bg_position":["default"],"metabox_title_box_bg_position_x":[""],"metabox_title_box_bg_position_y":[""],"metabox_title_box_bg_attachment":["default"],"title_box_bg_size":["default"],"metabox_title_box_bg_size_slider":[""],"title_box_bg_repeat":["default"],"disable_title":["default"],"title_box_title_color":[""],"title_box_title_line_color":[""],"disable_breadcrumbs":["default"],"metabox_title_box_breadcrumbs_color":[""],"metabox_title_box_links_color":[""],"metabox_title_box_links_color_hover":[""],"content_bg_transparent":[""],"show_popup_single":[""],"popups_single":[""],"popups_single_event":[""],"popup_single_event_open_delay":[""],"popup_single_event_showing_in":[""],"popup_single_event_date_from":[""],"popup_single_event_date_to":[""],"popup_single_event_time_from":[""],"popup_single_event_time_to":[""],"popup_single_animation":[""],"popup_single_responsive":[""],"separator_footer_copyright_border_t":[""],"name":[""],"email":[""],"phone":[""],"company":[""],"memberId":[""],"testimonial_position":[""],"testimonial_company":[""],"testimonial_bg_img":[""],"testimonial_video_url":[""],"popups_width":[""],"popups_height":[""],"popups_image_bg":[""],"popups_color_bg":[""],"popups_border_radius":[""],"popups_template":[""],"rank_math_analytic_object_id":["17609"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/06\/Why-Is-Jubilant-Pharmova-Share-Price-Falling.jpg","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116151","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/28"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=116151"}],"version-history":[{"count":2,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116151\/revisions"}],"predecessor-version":[{"id":116386,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/116151\/revisions\/116386"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/116385"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=116151"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=116151"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=116151"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}